Cargando…

Robot-Assisted Gait Training in Patients with Multiple Sclerosis: A Randomized Controlled Crossover Trial

Background and Objectives: Gait disorders represent one of the most disabling aspects in multiple sclerosis (MS) that strongly influence patient quality of life. The improvement of walking ability is a primary goal for rehabilitation treatment. The aim of this study is to evaluate the effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Sconza, Cristiano, Negrini, Francesco, Di Matteo, Berardo, Borboni, Alberto, Boccia, Gennaro, Petrikonis, Ignas, Stankevičius, Edgaras, Casale, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306232/
https://www.ncbi.nlm.nih.gov/pubmed/34356994
http://dx.doi.org/10.3390/medicina57070713
_version_ 1783727760591552512
author Sconza, Cristiano
Negrini, Francesco
Di Matteo, Berardo
Borboni, Alberto
Boccia, Gennaro
Petrikonis, Ignas
Stankevičius, Edgaras
Casale, Roberto
author_facet Sconza, Cristiano
Negrini, Francesco
Di Matteo, Berardo
Borboni, Alberto
Boccia, Gennaro
Petrikonis, Ignas
Stankevičius, Edgaras
Casale, Roberto
author_sort Sconza, Cristiano
collection PubMed
description Background and Objectives: Gait disorders represent one of the most disabling aspects in multiple sclerosis (MS) that strongly influence patient quality of life. The improvement of walking ability is a primary goal for rehabilitation treatment. The aim of this study is to evaluate the effectiveness of robot-assisted gait training (RAGT) in association with physiotherapy treatment in patients affected by MS in comparison with ground conventional gait training. Study design: Randomized controlled crossover trial. Materials and Methods: Twenty-seven participants affected by MS with EDSS scores between 3.5 and 7 were enrolled, of whom seventeen completed the study. They received five training sessions per week over five weeks of conventional gait training with (experimental group) or without (control group) the inclusion of RAGT. The patients were prospectively evaluated before and after the first treatment session and, after the crossover phase, before and after the second treatment session. The evaluation was based on the 25-foot walk test (25FW, main outcome), 6 min walk test (6MWT), Tinetti Test, Modified Ashworth Scale, and modified Motricity Index for lower limbs. We also measured disability parameters using Functional Independence Measure and Quality of Life Index, and instrumental kinematic and gait parameters: knee extensor strength, double-time support, step length ratio; 17 patients reached the final evaluation. Results: Both groups significantly improved on gait parameters, motor abilities, and autonomy recovery in daily living activities with generally better results of RAGT over control treatment. In particular, the RAGT group improved more than control group in the 25FW (p = 0.004) and the 6MWT (p = 0.022). Conclusions: RAGT is a valid treatment option that in association with physiotherapy could induce positive effects in MS-correlated gait disorders. Our results showed greater effectiveness in recovering gait speed and resistance than conventional gait training.
format Online
Article
Text
id pubmed-8306232
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83062322021-07-25 Robot-Assisted Gait Training in Patients with Multiple Sclerosis: A Randomized Controlled Crossover Trial Sconza, Cristiano Negrini, Francesco Di Matteo, Berardo Borboni, Alberto Boccia, Gennaro Petrikonis, Ignas Stankevičius, Edgaras Casale, Roberto Medicina (Kaunas) Article Background and Objectives: Gait disorders represent one of the most disabling aspects in multiple sclerosis (MS) that strongly influence patient quality of life. The improvement of walking ability is a primary goal for rehabilitation treatment. The aim of this study is to evaluate the effectiveness of robot-assisted gait training (RAGT) in association with physiotherapy treatment in patients affected by MS in comparison with ground conventional gait training. Study design: Randomized controlled crossover trial. Materials and Methods: Twenty-seven participants affected by MS with EDSS scores between 3.5 and 7 were enrolled, of whom seventeen completed the study. They received five training sessions per week over five weeks of conventional gait training with (experimental group) or without (control group) the inclusion of RAGT. The patients were prospectively evaluated before and after the first treatment session and, after the crossover phase, before and after the second treatment session. The evaluation was based on the 25-foot walk test (25FW, main outcome), 6 min walk test (6MWT), Tinetti Test, Modified Ashworth Scale, and modified Motricity Index for lower limbs. We also measured disability parameters using Functional Independence Measure and Quality of Life Index, and instrumental kinematic and gait parameters: knee extensor strength, double-time support, step length ratio; 17 patients reached the final evaluation. Results: Both groups significantly improved on gait parameters, motor abilities, and autonomy recovery in daily living activities with generally better results of RAGT over control treatment. In particular, the RAGT group improved more than control group in the 25FW (p = 0.004) and the 6MWT (p = 0.022). Conclusions: RAGT is a valid treatment option that in association with physiotherapy could induce positive effects in MS-correlated gait disorders. Our results showed greater effectiveness in recovering gait speed and resistance than conventional gait training. MDPI 2021-07-14 /pmc/articles/PMC8306232/ /pubmed/34356994 http://dx.doi.org/10.3390/medicina57070713 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sconza, Cristiano
Negrini, Francesco
Di Matteo, Berardo
Borboni, Alberto
Boccia, Gennaro
Petrikonis, Ignas
Stankevičius, Edgaras
Casale, Roberto
Robot-Assisted Gait Training in Patients with Multiple Sclerosis: A Randomized Controlled Crossover Trial
title Robot-Assisted Gait Training in Patients with Multiple Sclerosis: A Randomized Controlled Crossover Trial
title_full Robot-Assisted Gait Training in Patients with Multiple Sclerosis: A Randomized Controlled Crossover Trial
title_fullStr Robot-Assisted Gait Training in Patients with Multiple Sclerosis: A Randomized Controlled Crossover Trial
title_full_unstemmed Robot-Assisted Gait Training in Patients with Multiple Sclerosis: A Randomized Controlled Crossover Trial
title_short Robot-Assisted Gait Training in Patients with Multiple Sclerosis: A Randomized Controlled Crossover Trial
title_sort robot-assisted gait training in patients with multiple sclerosis: a randomized controlled crossover trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306232/
https://www.ncbi.nlm.nih.gov/pubmed/34356994
http://dx.doi.org/10.3390/medicina57070713
work_keys_str_mv AT sconzacristiano robotassistedgaittraininginpatientswithmultiplesclerosisarandomizedcontrolledcrossovertrial
AT negrinifrancesco robotassistedgaittraininginpatientswithmultiplesclerosisarandomizedcontrolledcrossovertrial
AT dimatteoberardo robotassistedgaittraininginpatientswithmultiplesclerosisarandomizedcontrolledcrossovertrial
AT borbonialberto robotassistedgaittraininginpatientswithmultiplesclerosisarandomizedcontrolledcrossovertrial
AT bocciagennaro robotassistedgaittraininginpatientswithmultiplesclerosisarandomizedcontrolledcrossovertrial
AT petrikonisignas robotassistedgaittraininginpatientswithmultiplesclerosisarandomizedcontrolledcrossovertrial
AT stankeviciusedgaras robotassistedgaittraininginpatientswithmultiplesclerosisarandomizedcontrolledcrossovertrial
AT casaleroberto robotassistedgaittraininginpatientswithmultiplesclerosisarandomizedcontrolledcrossovertrial